Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The biopharmaceutical group Ipsen has released the data for the liquidity contract entrusted to Natixis Oddo BHF for the second half of 2025. As of De…
The French biopharmaceutical group has entered into an exclusive licensing agreement with Simcere Zaiming for SIM0613, an experimental antibody-drug c…
French laboratory Ipsen has announced the discontinuation of its Phase II FALKON trial on fidrisertib, following the failure to meet the primary endpo…
The French pharmaceutical group announced this Sunday that it has completed the acquisition of ImCheck Therapeutics, a private French company speciali…
Ipsen has announced the transfer of shares from Beech Tree company to the Alasol Foundation, in accordance with the wishes of Mr. Henri Beaufour.
Ipsen announces the passing of Henri Beaufour, influential board member, which occurred on November 28, 2025.
According to a press release, Ipsen conducted several transactions on its own shares between November 10 and November 14, 2025.
IPSEN stock has shown positive dynamics over the past week, accelerating compared to the general trend of French indices. This development occurs in a…
IPSEN ends the day on a strong upward trend, breaking through key technical thresholds at close. Priced at 127 euros, the pharmaceutical giant's stock…
Ipsen announced the presentation of new data from the ELATIVE trial on Iqirvo, a treatment for primary biliary cholangitis, at The Liver Meeting 2025.
